EyePoint, Inc. Increase (Decrease) in Accrued Liabilities
EyePoint, Inc. (EYPT) reported Increase (Decrease) in Accrued Liabilities of $94.00 thousand for the 6-month period ending 2018-12-31, per its 10-KT filed 2019-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-03-18
- EyePoint, Inc. increase (decrease) in accrued liabilities for fiscal 2018 was -$585.00K, a 190.00% decline from fiscal 2017.
- EyePoint, Inc. increase (decrease) in accrued liabilities for fiscal 2017 was $650.00K, a 37.26% decline from fiscal 2016.
- EyePoint, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was $1.04M, a 1.61% decline from fiscal 2015.
- EyePoint, Inc. increase (decrease) in accrued liabilities for fiscal 2015 was $1.05M.
| Period end | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|
| 2018-12-31 | $94.00K 10-KT · filed 2019-03-18 | |
| 2018-06-30 | -$585.00K 10-KT · filed 2019-03-18 | |
| 2017-06-30 | $650.00K 10-KT · filed 2019-03-18 | |
| 2016-06-30 | $1.04M 10-KT · filed 2019-03-18 | |
| 2015-06-30 | $1.05M 10-K · filed 2017-09-13 | |
| 2014-06-30 | -$381.00K 10-K · filed 2016-09-13 | |
| 2013-06-30 | $1.29M 10-K · filed 2015-09-10 | |
| 2012-06-30 | -$712.00K 10-K · filed 2014-09-11 | |
| 2011-06-30 | $146.00K 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |